TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$67.45
-1.62 (-2.35%)
Performance
1D
—
1W
-9.89%
1M
-8.37%
3M
-0.46%
6M
+13.08%
1Y
-0.94%
YTD
-16.49%
Open$69.25
Previous Close$69.07
Day High$70.95
Day Low$67.14
52W High$91.53
52W Low$53.89
Volume—
Avg Volume912.8K
Market Cap3.69B
P/E Ratio—
EPS$-1.08
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$75.12
Below
SMA 200
$67.78
Below
RSI (14)
46
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+20.9% upside
Current
$67.45
$67.45
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 533.37M | 141.37M | 563.29M |
| Net Income | -78,488,050 | -80,362,652 | 118.73M |
| Profit Margin | -14.7% | -60.0% | 21.1% |
| EBITDA | -82,852,886 | -89,061,843 | 174.10M |
| Free Cash Flow | — | — | 127.20M |
| Rev Growth | +159.5% | +47.5% | +0.6% |
| Debt/Equity | 0.21 | 0.32 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |